Background: Intratumor heterogeneity of hepatocellular carcinoma (HCC) and, among HCC cell subsets, the cancer stem cell population (hCSC), is responsible for therapeutic resistance and disease relapse. Aims: To characterize hCSC-enriched HCCs at the molecular level. Methods: Side population (SP) was used to identify the hCSCs in multiple tumor sampling from different patients and primary HCCs cultures. FACS was used to immunoprofile cultures. miRNAs were profiled in samples and correlated to SP. The Cancer Genome Atlas (TCGA) HCC dataset was analyzed to search for signatures associated with C19MC miRNAs expression. Results were confirmed by immunohistochemistry. Results: The miRNA cluster on chromosome 19 (C19MC) was enriched in SP and in HCCs with a high SP fraction. At the molecular level, an elevated C19MC was correlated with expression of precursor transcripts. In TCGA-HCC series, high C19MC expression identified a subset of patients with poorer prognosis, advanced disease and overexpression of the cancer-testis (CT) antigens. These data were confirmed in an independent cohort of HCCs and at the protein level. Conclusion: C19MC miRNAs and CT antigens overexpression represents a novel oncogenic pathway in a subset of hCSC-enriched HCCs with dismal prognosis. CT antigens are promising immunotherapy targets. Therefore, these molecular signatures could identify HCCs who could benefit from immunotherapy.
Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature / C. Augello, F. Colombo, A. Terrasi, E. Trombetta, M. Maggioni, L. Porretti, G. Rossi, S. Guerneri, R. Silipigni, S. Bosari, V. Vaira. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 50:6(2018 Jun), pp. 583-593.
Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature
C. AugelloCo-primo
;A. Terrasi;G. Rossi;R. Silipigni;S. Bosari
;V. Vaira
Ultimo
2018
Abstract
Background: Intratumor heterogeneity of hepatocellular carcinoma (HCC) and, among HCC cell subsets, the cancer stem cell population (hCSC), is responsible for therapeutic resistance and disease relapse. Aims: To characterize hCSC-enriched HCCs at the molecular level. Methods: Side population (SP) was used to identify the hCSCs in multiple tumor sampling from different patients and primary HCCs cultures. FACS was used to immunoprofile cultures. miRNAs were profiled in samples and correlated to SP. The Cancer Genome Atlas (TCGA) HCC dataset was analyzed to search for signatures associated with C19MC miRNAs expression. Results were confirmed by immunohistochemistry. Results: The miRNA cluster on chromosome 19 (C19MC) was enriched in SP and in HCCs with a high SP fraction. At the molecular level, an elevated C19MC was correlated with expression of precursor transcripts. In TCGA-HCC series, high C19MC expression identified a subset of patients with poorer prognosis, advanced disease and overexpression of the cancer-testis (CT) antigens. These data were confirmed in an independent cohort of HCCs and at the protein level. Conclusion: C19MC miRNAs and CT antigens overexpression represents a novel oncogenic pathway in a subset of hCSC-enriched HCCs with dismal prognosis. CT antigens are promising immunotherapy targets. Therefore, these molecular signatures could identify HCCs who could benefit from immunotherapy.File | Dimensione | Formato | |
---|---|---|---|
AIR OK-Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
580.01 kB
Formato
Adobe PDF
|
580.01 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.